Skip to main navigation Skip to search Skip to main content

STTR: An adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment

Project: Research

Project Details

StatusFinished
Effective start/end date02/10/2004/30/22

Funding

  • National Institute of Allergy & Infectious Disease: $134,246.00